{
    "nctId": "NCT04239560",
    "briefTitle": "Preventive Effect of Boron-based Gel on Radiation Dermatitis",
    "officialTitle": "Preventive Effect of Boron-based Gel on Radiation Dermatitis in Patients With Breast Cancer: Phase III Randomized, Double-blind, Placebo-controlled Clinical Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Radiodermatitis",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 257,
    "primaryOutcomeMeasure": "Radiation Therapy Oncology Group (RTOG) criteria",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who are admitted to the study are enrolled in the study and have head and neck cancer in the breast, and are between the ages of 18 and 75 years old and have not received radiotherapy before.\n\nExclusion Criteria:\n\n* Pregnant women, patients with unknown dermatitis and those without any willing to participate in this study were excluded.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}